Notification Letter and Request Form to Non-registered Holder
Filed with HKEX · Stock code 460 · · 2 pages · English and Chinese
Summary by 6ix AI
The letter informs recipients that both English and Chinese versions of the report are available on the company's website and the HKExnews website. It also includes a request form for those who wish to receive printed copies of future corporate communications. The company encourages holders to provide their email addresses to facilitate electronic communication.
Written by 6ix AI from the company’s filing. How 6ix writes summaries
Sihuan Pharmaceutical Holdings Group Ltd. on 6ix
Earlier from Sihuan Pharmaceutical
- Notification Letter and Change Request Form to Registered Shareholder
- Interim Report 2026
- Voluntary announcement - insulin aspart 30 injection developed by Sihuan Pharmaceutical achieved equivalent clinical results in efficacy and safety study as originator drug
- Voluntary announcement-entering into strategic cooperation agreement between jilin huisheng biopharmaceutical and porton pharma
- Voluntary announcement - share repurchase
Later from Sihuan Pharmaceutical
- Monthly Return of Equity Issuer on Movements in Securities for the month ended 30 September 2026
- Voluntary announcement - new specifications of skin booster (brand name: dongyan) of Sihuan Pharmaceutical approved for launch by nmpa
- Voluntary announcement-Sihuan Pharmaceutical completed a strategic investment in canton biologics to enhance the layout of the entire industrial chain of regenerative medical aesthetics
- Voluntary announcement - polycaprolactone microsphere facial filler for Injection and hyaluronic acid sodium composite solution for Injection independently developed by meiyan space, a subsidiary of Sihuan Pharmaceutical, approved for market launch in hong kong
- Voluntary announcement- phase III clinical study data of xuanzhu biopharm's Anaprazole Sodium for reflux esophagitis presented at UEG Week 2026
Follow Sihuan Pharmaceutical into a list and get an email when it puts out news.
Follow Sihuan Pharmaceutical